A retinoid X receptor (RXR)-selective retinoid reveals that RXR-α is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

A retinoid X receptor (RXR)-selective retinoid reveals that RXR-α is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands

Authors:	David L Crowe and Roshantha AS Chandraratna

Affiliation:	(1) Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles, California, USA;(2) Division of Retinoid Research, Allergan, Irvine, California, USA

Abstract:

Keywords:
本文献已被 SpringerLink 等数据库收录！